Literature DB >> 24767380

Risk factors and prognosis of patients with primary graft failure after heart transplantation: an Asian center experience.

J-W Chen1, Y-S Chen1, N-H Chi1, S-C Huang1, H-Y Yu1, N-K Chou1, C-H Wang1, S-S Wang2.   

Abstract

BACKGROUND: Although primary graft failure (PGF) after heart transplantation is a feared complication, most reports have come from Western countries. We analyzed the incidence in our hospital and tried to determine the predictive risk factors for PGF that require mechanical circulatory support or high dosage of inotropic agents after heart transplantation. We observed the long-term prognosis of patients successfully surviving PGF.
METHODS: For this retrospective review, 447 patients undergoing heart transplantation between January 1990 and January 2013 were enrolled in our study. We compared the clinical data between patients with PGF and without PGF. The risk factors associated with PGF were analyzed, and the long-term survival curve was analyzed using a Kaplan-Meier analysis.
RESULTS: The incidence of PGF in our study was 36.2% (162 patients) and the overall PGF-related mortality rate was 17% (30 day in-hospital mortality). Independent risk factors for PGF included preoperative recipient hypoalbuminemia, high central venous pressure, United Network for Organ Sharing (UNOS) status 1A, dependence on inotropic agents, ventilator, intra-aortic balloon pump (IABP), and extracorporeal membrane oxygenation (ECMO), and longer ischemic time. Patients with PGF had poorer long-term survival than patients without PGF; the 1-year survival rate was 40% versus 76% (P < .01). The rate of weaning from ECMO for PGF was 46% (12 of 26 patients) and they have similar 1-year survival rates as non-EGF patients.
CONCLUSIONS: Several recipient and donor variables significantly influenced the PGF after heart transplantation. The mortality rate was higher in patients with PGF. However, patients who survived PGF have similar mid-term and long-term survival as patients without PGF.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24767380     DOI: 10.1016/j.transproceed.2013.11.107

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  4 in total

1.  Extracorporeal membrane oxygenation as treatment of graft failure after heart transplantation.

Authors:  Ciro Mastroianni; Antonio Nenna; Guillaume Lebreton; Cosimo D'Alessandro; Salvatore Matteo Greco; Mario Lusini; Pascal Leprince; Massimo Chello
Journal:  Ann Cardiothorac Surg       Date:  2019-01

2.  Life impact of VA-ECMO due to primary graft dysfunction in patients after orthotopic heart transplantation.

Authors:  René M'Pembele; Sebastian Roth; Alexandra Stroda; Giovanna Lurati Buse; Stephan U Sixt; Ralf Westenfeld; Amin Polzin; Philipp Rellecke; Igor Tudorache; Markus W Hollmann; Hug Aubin; Payam Akhyari; Artur Lichtenberg; Ragnar Huhn; Udo Boeken
Journal:  ESC Heart Fail       Date:  2021-11-04

3.  Amiodarone Use Prior to Cardiac Transplant Impacts Early Post-Transplant Survival.

Authors:  Salman S Allana; Furqan A Rajput; Jason W Smith; Lucian Lozonschi; Jinn-Ing Liou; Maryl Johnson; Takushi Kohmoto; Ravi Dhingra
Journal:  Cardiovasc Drugs Ther       Date:  2020-10-19       Impact factor: 3.727

4.  Status on Heart Transplantation in China.

Authors:  Xing-Jian Hu; Nian-Guo Dong; Jin-Ping Liu; Fei Li; Yong-Feng Sun; Yin Wang
Journal:  Chin Med J (Engl)       Date:  2015-12-05       Impact factor: 2.628

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.